Valuation: Kintor Pharmaceutical Limited

Market Cap 764M 891M 114M 97.39M 91.12M 83.41M 157M 10.88B 159M 1.08B 420M 5.46B 427M 418M 18.07B P/E 2024
-2.53x
P/E 2025 -3.96x
Enterprise Value 818M 954M 122M 104M 97.54M 89.29M 168M 11.64B 170M 1.15B 449M 5.85B 457M 447M 19.35B EV / Sales 2024
75,794,130x
EV / Sales 2025 28,245,180x
Free-Float
88.01%
Yield 2024 *
-
Yield 2025 -
1 day+6.49%
1 week-2.17%
Current month+6.18%
1 month+5.56%
3 months-31.37%
6 months-33.39%
Current year-7.91%
1 week 1.62
Extreme 1.615
1.88
1 month 1.6
Extreme 1.605
2.06
Current year 1.6
Extreme 1.605
4.7
1 year 1.6
Extreme 1.605
4.7
3 years 0.79
Extreme 0.79
4.7
5 years 0.79
Extreme 0.79
89
10 years 0.79
Extreme 0.79
89
Manager TitleAgeSince
Chief Executive Officer 64 2009-03-23
Director of Finance/CFO 49 2023-04-13
Chief Tech/Sci/R&D Officer 49 2020-08-31
Director TitleAgeSince
Director/Board Member 62 2019-08-11
Director/Board Member 61 2019-08-11
Chairman 64 2009-03-23
Date Insider Type Main position Quantity % Market Cap.
7/17/26 Other

Chief Executive Officer

145,000 0.0291%
1/23/26 Other

Chief Executive Officer

150,000 0.0301%
1/22/26 Other

Chief Executive Officer

300,000 0.0602%
Change 5-day change 1-year change 3-year change Capi.($)
+6.49%-2.17%-24.16%-49.86% 114M
-3.00%+2.27%+73.26%+109.90% 72.12B
+1.90%+23.53%+59.48%+94.82% 65.85B
+5.12%+25.22%+5.13%-5.86% 29.28B
+0.55%+1.64%-4.63%+480.92% 27.47B
+2.74%+12.98%+54.92%+25.77% 26.7B
+0.47%+6.12%+37.01%-15.31% 20.06B
+1.82%-6.67%+251.36%+388.91% 18.22B
+0.94%+3.36%+15.30%+548.19% 16.4B
+0.73%+5.54%+39.99%+151.77% 13.4B
Average +1.78%+7.31%+50.77%+172.92% 28.96B
Weighted average by Cap. +0.74%+9.48%+57.99%+157.78%

Financials

2024 2025
Net sales 5 5.83 0.74 0.64 0.6 0.55 1.02 71.16 1.04 7.04 2.75 35.75 2.79 2.73 118.24 32.68 38.12 4.86 4.16 3.9 3.57 6.69 465.16 6.78 46.04 17.95 233.67 18.26 17.86 772.89
Net income -155M -181M -23.1M -19.79M -18.52M -16.95M -31.81M -2.21B -32.23M -219M -85.31M -1.11B -86.74M -84.85M -3.67B -200M -233M -29.77M -25.5M -23.86M -21.84M -40.99M -2.85B -41.53M -282M -110M -1.43B -112M -109M -4.73B
Net Debt -15.68M -18.29M -2.33M -2M -1.87M -1.71M -3.21M -223M -3.25M -22.09M -8.61M -112M -8.76M -8.57M -371M 53.86M 62.82M 8.01M 6.86M 6.42M 5.88M 11.03M 767M 11.18M 75.87M 29.59M 385M 30.08M 29.43M 1.27B
Logo Kintor Pharmaceutical Limited
Kintor Pharmaceutical Ltd is an investment holding company primarily engaged in the research and development of innovative medicine products. The Company's products are dedicated to addressing disease areas that have not met clinical needs, and its pipeline mainly covers indications of dermatology (such as androgenetic alopecia, acne vulgaris) and indications of tumors. The Company has two core drugs in the dermatology field, KX-826 and GT20029. The Company's other disease areas include metastatic castration-resistant prostate cancer (mCRPC), liver cancer, idiopathic pulmonary fibrosis, malignant blood diseases and various solid tumors.
Employees
123
Date Price Change Volume
26-08-21 HK$1.805 +6.49% 1,444,500
26-08-20 HK$1.695 -3.14% 2,382,500
26-08-19 HK$1.750 +2.94% 903,000
26-08-18 HK$1.700 -8.36% 1,406,000
26-08-17 HK$1.855 +0.54% 257,000

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 9939 Stock